Provided here are links that highlight relevant milestones and news for Juvabis.
For more up-to-date information, please visit our LinkedIn profile.
Visit our LinkedIn profile
Meet Venture Leader Sven N. Hobbie's Next-Generation Aminoglycoside Antibiotics's Startup
Juvabis' fight against antimicrobial resistance continues in first in-human clinical trials
A very promising new antibiotic just started clinical trials
Researchers from ENABLE are hopeful about EBL-1003 because it has passed the stage at which most potential antibiotics fail.